進階篩選

Technical category
    • Application of inorganic nanofiber technology to promote the development of biotechnology

      Smart machinerynovel materials FutureTech Application of inorganic nanofiber technology to promote the development of biotechnology

      Inorganic porous nanofibers with surfaceinterface defects are prepared through humidity-controlled electrospinninghigh-temperature annealing technology. Under the irradiation of light sources of different wavelengths (380~780 nm), the bound electrons stored in the valence band can be excited to the conduction band to form free electrons on the surface of the material, generating different intensities of microcurrents, light sensitivitymicrocurrent changes. Because the "inorganic nanofiber" technology has high uniquenesshigh product compatibility, it can be applied to a wide range of markets.
    • (test)Application of inorganic nanofiber technology to promote the development of biotechnology

      Smart machinerynovel materials FutureTech (test)Application of inorganic nanofiber technology to promote the development of biotechnology

      Inorganic porous nanofibers with surfaceinterface defects are prepared through humidity-controlled electrospinninghigh-temperature annealing technology. Under the irradiation of light sources of different wavelengths (380~780 nm), the bound electrons stored in the valence band can be excited to the conduction band to form free electrons on the surface of the material, generating different intensities of microcurrents, light sensitivitymicrocurrent changes. Because the "inorganic nanofiber" technology has high uniquenesshigh product compatibility, it can be applied to a wide range of markets.
    • 智能精準放射治療系統研發

      FutureTech 智能精準放射治療系統研發

      This technology uses deep learning technology to establish six automatic organ segmentation models for six organsa graphical user interface for doctors. The data is exchanged with the existing radiotherapy planning system by standard formats. Analysis of the dosimetric parameters of the 3D printed customized bolus demonstrated that it is provided good dose escalationgood contact with the irregular surface.
    • 肝癌治療成效追蹤與術後復發預測輔助系統

      FutureTech 肝癌治療成效追蹤與術後復發預測輔助系統

      "The primary goal of this project is to establish a complete hospital-based liver cancer database, profiles for data feature extraction,develop different cancer, prediction models. A Medical AI program to predict the poster treatment (including operationradiofrequency ablation) recurrence of liver cancer will be established. The program system will assist doctors in the medical decision, identify high-risk patients,adjust clinical follow-up programs."
    • 非病毒磁性基因傳遞技術及其細胞治療應用

      FutureTech 非病毒磁性基因傳遞技術及其細胞治療應用

      Gene delivery technology is widely used in cell therapy, nucleic acid-based vaccines, protein production, gene therapy, etc. We have developed a non-viral gene delivery technology-MPGene, which has excellent gene delivery efficiency (50-80) for human mesenchymal stem cells,also has the characteristics of low production costhigh safety. In the future, MPGene has the potential to be used in important biomedical fields such as gene delivery reagents, major trauma cell therapy, malignant tumor treatmentcartilage cell therapy.
    • 個人化精準腫瘤治療顧問-腦轉移腫瘤

      FutureTech 個人化精準腫瘤治療顧問-腦轉移腫瘤

      PCA-BM includes two models: “Automatic BMs Segmentation AI Model”" Distant Brain Failure Prediction Model". The former one uses C2FNAS (coarse to fine network architecture search) to detect the location, size,number of brain metastases. The latter uses radiomics to extract numerous radiographic featuresemploys machine learning methods such as XGBoost to establish a prognostic model of brain metastases. PCA-BM provides more precision treatment decisions for patientsimproves personalizedaccurate overall stereotactic radiosurgery planning.
    • Novel Therapy for Critical Limb Ischemia

      Precision Health Ecosystem FutureTech Novel Therapy for Critical Limb Ischemia

      We used the concepts of tissue regeneration, embedding drugs in biomaterial carriers,a rigorous regeneration deficient animal model with severe hind limb ischemia to develop an effective novel therapy Grace-001. The new drug can promote neovascularization, tissue regeneration, blood flow maintenance,restoration of blood vessels, nerves,muscles as well as their functions. This new dr
    • 以CXCR4受體為分子標的之急性心肌梗塞治療藥物開發

      FutureTech 以CXCR4受體為分子標的之急性心肌梗塞治療藥物開發

      DBPR807, a safehighly specific CXCR4-targeting antagonist, has completed the concept validation of treating acute myocardial infarction (AMI) through both ratmini-pig animal disease models induced by occluding the left anterior descending artery (LAD). When DBPR807 (5 mg/kg, SC) was given in the rat model, a significant heart-protective effect was observed with reducing cardiac infarctionfibrosis by 4341, respectively. In the mini-pig model, DBPR807 (3 mg/kg, IV) treatment was allowed to improve 3-month LVEF up to 52 falling in a standard range between 50~70.
    • 專用於細胞免疫治療的成體幹細胞體外增殖誘導與冷凍保存整合系統

      FutureTech 專用於細胞免疫治療的成體幹細胞體外增殖誘導與冷凍保存整合系統

      The invention integrates a variety of technologies including stem cell proliferation, directed inductioncryopreservation in vitro. This integrated system was developed under chemical defined condition,can expand various type of stem cells over one hundred foldcan furtherly induce to specific mature cells up to ten millions. In addition, the amount of cryoprotectant can be significantly reduced to 2 in the cryopreservation system with excellent cell survival rate. This integrated system can provide a promisingvarious stem cell sources for cell therapyimmunotherapy.
    • Bi-specific antibodiesuses thereof

      Bio-tech & New Drugs FutureTech Bi-specific antibodiesuses thereof

      We developed a humanized bifunctional antibody (mPEG×tumor marker),the anti-PEG end can be non-covalently modified to bind any PEGylated nano-druga contrast agent by one-step "formulation". The non-covalent binding solved the problems of chemical modification such as the masking of the antibody binding site, heterogeneity, drug instability. The other end of the bifunctional antibody can specifical
    • 治療多種癌症與纖維化之首創抗體新藥

      FutureTech 治療多種癌症與纖維化之首創抗體新藥

      Ninety percent of human diseases are related to abnormal inflammation. WJM team has successfully developed a new monoclonal antibody that can inhibit a key inflammation protein. Animal experiments have accumulated more than ten disease modes, including a variety of solid tumors, fibrosis, degenerativecardiovascular diseases. This antibody is qualified as an orphan drug for the treatment of IPF. New coronary pneumonia has greatly increased the demand for pulmonary fibrosis treatment,has also become an important target for mergersacquisitions of global pharmaceutical companies.
    • 抗癌小分子新藥之臨床前開發與精準治療策略

      FutureTech 抗癌小分子新藥之臨床前開發與精準治療策略

      MPT0G211 is a highly selective HDAC6 inhibitor, with comprehensive IP protection. MPT0G211 is mainly focused on multiple myelomabrain tumor indications. For IND package, we have completed CMC in drug substance, CMC in drug product, ADME,most preclinical toxicology studies, only the 28-days repeated dose toxicology study in dog is left. Once the 28-day repeated dose toxicology study in dog is completed, the IND package will be filed in the United StatesTaiwan in Q2 2022.
    • 智慧型偏頭痛預警及神經電刺激輔助治療系統

      FutureTech 智慧型偏頭痛預警及神經電刺激輔助治療系統

      Migraine patients account for about 640 million people (15) in the world,about 1.75 million (9.1) in Taiwan. Our team had developed a wearable brain-computer interface system with the newly developed graphene dry electrodeadaptive noise subspace reconstruction technology. This system combined the physiological indicators before migraine attacksuses AI technology to build an intelligent migraine early warning system,combined BrainSTIM electrical stimulation technology to assist migraine patients.
    • 結合奈米技術與CRISPR/Cas9基因編輯應用於治療遺傳性疾病

      FutureTech 結合奈米技術與CRISPR/Cas9基因編輯應用於治療遺傳性疾病

      Supramolecular nanoparticles is a convenient, flexible,modular synthetic non-viral gene delivery vehicle for drug/gene delivery. The self-assembly of SMNPs is enabled upon mixing three different molecular building blocks, namely CD-PEI, Ad-PAMAM,Ad-PEG via Ad/CD motif-based molecular recognition. This allows modular control over the sizes, surface chemistry,payloads of SMNP vectors, thus holding promise for diverse therapeutic applications, especially for developing nanoparticle-based gene delivery platforms.
    • 創新壓迫性骨折治療技術-“脊固立”脊椎椎體復位強化系統

      FutureTech 創新壓迫性骨折治療技術-“脊固立”脊椎椎體復位強化系統

      “Tripod-Fix”, that is promising in every class of VCFmost importantly in wedge fracture is needed. “Tripod-Fix” made by titanium uses triangular pyramid-like design with three-dimensional expansion mechanism to increase stability against verticalhorizontal forces during placement. The advantages for Tripod-Fix treatment are to fix the angle of spine, stabilize the VB,insert the cement to avoid re-collapse. It is an effectivelow-risk restoration product for patients with VCF allowing a fastsustained improvement in quality of life.
    • 以幾丁聚醣鼻噴劑促進嗅覺神經上皮再生治療嗅覺失常

      FutureTech 以幾丁聚醣鼻噴劑促進嗅覺神經上皮再生治療嗅覺失常

      The prevalence of olfactory dysfunction increases significantly in recent years. More than 35 patients with COVID-19 have sequelae of olfactory dysfunction after recovery. However, there are no effective treatments for sensorineural olfactory dysfunction to date. This is the first report demonstrates that chitosan can promote differentiation of olfactory receptor neuronsregenerate olfactory neuroepithelium. Further intranasal administration of chitosan will be developed for treating olfactory dysfunction.
    • 抗菌胜肽epinecidin-1當作佐劑用於預防或治療病毒性疾病之應用

      FutureTech 抗菌胜肽epinecidin-1當作佐劑用於預防或治療病毒性疾病之應用

      A method of enhancing a mammalian immune response to a virus is disclosed. The method comprises administering a composition comprising an effective amount of epinecidin (Epi)-1the virus to a mammal, wherein the virus has envelope proteinis infectious to the mammal. In this technique, Epi-1Japanese encephalitis virus (JEV) were mixedinjected into mice. The mice were infected with JEV 14 days later,all mice survived. This technology has also been verified in the preparation of vaccines for foot-and-mouth disease virusnervous necrosis virus.
    • 人工智慧於息肉狀脈絡膜血管病變之診斷與治療決策之應用

      AI & IOT Application FutureTech 人工智慧於息肉狀脈絡膜血管病變之診斷與治療決策之應用

      This system help doctors to distinguish age-related macular degeneration (ARMD)polypoidal choroidal vasculopathy (PCV) by color fundus photography. We have collected large image dataset from Taipei Veterans General Hospitalother hospitals to establishvalidate CNN model, which had been tested by external image datasetmodified to improve the accuracy of the AI model.
    • BPRSJ338: Therapeutic Applications for COVID-19

      Precision Health Ecosystem FutureTech BPRSJ338: Therapeutic Applications for COVID-19

      BPRSJ338 exhibits high potency of anti-SARS-CoV-2 activity and is in development for fighting COVID-19 as a first-in-class drug. BPRSJ338 also potently inhibits against broad-spectrum coronaviruses including SARS-CoV-2, SARS-CoV, HCoV-229E, HCoV-OC43, TGEV, FIPV and MHV. Related US and Taiwan patents have been granted.​ Therefore it is also applicable to fight against severe evolving coronaviruses in the future.
    • 運用合成抗體庫發展治療與診斷人類疾病用抗體的抗體技術平台

      FutureTech 運用合成抗體庫發展治療與診斷人類疾病用抗體的抗體技術平台

      We provide antibody-based solutions to human diseases with short development course at low cost, are based on the phage-displayed GH (Generic Human) synthetic antibody libraries designedconstructed with enabling approaches, leading to the throughput capacities to uplift the innovativenessproductivity in developing antibody therapeuticsdiagnostics. In conjunction with the core technologies, antibody bioinformatics capable of extracting knowledge from big data of human antibody repertoires is used to elucidate human antibody responsesto assist antibody library design.
    • 具有頂級轉換效率之創新醫療雷射系統:用於眼部與皮膚疾病治療

      FutureTech 具有頂級轉換效率之創新醫療雷射系統:用於眼部與皮膚疾病治療

      We originally design a highly efficient NdYVO4/KGW Raman laser at 579.5 nm. The KGW crystal is specially coated to prevent the Stokes wave from propagating through the gain medium so as to minimize the cavity losses. Moreover, we explore a new output coupler with double-sided dichroic coating to exterminate the leakage power of the Stokes wave to lead to a remarkable improvement for the output efficiency. The maximum output power can be up to 10.5W at a pump power of 40W. The conversion efficiency of the diode pump light to yellow laser output can be increased to 26.3.
    • 創新可撓式PPG貼片及APP用於有心率變異生理回饋的憂鬱症數位治療

      FutureTech 創新可撓式PPG貼片及APP用於有心率變異生理回饋的憂鬱症數位治療

      This successful technology is the digital interventions on depression patients based on (1) heart rate variability bio-feedbacks (HRVBs) measured by a novel flexible sensor patch attached on patient’s wrist(2) an APP. An innovative flexible low-power PPG patch has been designed which is capable of providing weeks of high-quality PPG signals which are essential towards accurate estimation of HRV for favorable efficacy of designed digital interventions. Also, An AI model correlating the HRVsand PHQ-9/HDRS scores of depression patients will be built based on collected data.
    • A therapeutic gel for diabetic wounds

      Bio-tech & New Drugs FutureTech A therapeutic gel for diabetic wounds

      Our results have demonstrated that our tissue gel can effectively promote angiogenesiswound healing in diabetic wounds. Our product prototype will be a powerful therapeutic product to treat diabetic foot ulcersgo further to rescue diabetic patients from amputation.
    • A genomic marker guided roadmap to treat hepatocellular carcinoma

      Bio-tech & New Drugs FutureTech A genomic marker guided roadmap to treat hepatocellular carcinoma

      This is a method for identifying single nucleotide polymorphisms (GALNT14 genotypes) of a target nucleic acid for predicting whether a patient suffering from HCC will respond to combination chemotherapy. Accordingly, physicians can decide whether the HCC patients should receive chemotherapyTACE. This method could also predict prognosis in multiple gastrointestinal cancers.
    • Composition for treating lung fibrosisemphysematherapeutic method using the same

      Bio-tech & New Drugs FutureTech Composition for treating lung fibrosisemphysematherapeutic method using the same

      This is a regenerative biomedical technology, which aims to address the human chronic lung diseases that currently has no pharmaceutical approach for efficient controltherapy, such as COPDlung fibrosis. The principle is to induce the in vivo reprogramming of endogenous alveolar epithelial cells through activation of stemness factor BMI1, which potentiates the repair of injured tissues.
    • Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      Bio-tech & New Drugs FutureTech Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      PPARγ is the master regulator of glucose metabolism.15-keto-PGE2 is an endogenous PPARγ ligand whitch is degraded by ZADH1. We found that increasing 15-keto-PGE2 promotes glucose uptake. We identified several ZADH1 inhibitors which could increase 15-keto-PGE2 promote glucose uptake via activating PPARγ. Our results showed that inhibition of ZADH1 is a novel approach to treat type 2 diabes mell
    • A High Frequency Ventilator and Electrical Impedance Tomography for Respiratory Treatment

      Precision Health Ecosystem FutureTech A High Frequency Ventilator and Electrical Impedance Tomography for Respiratory Treatment

      The high-frequency jet ventilator uses the solenoid valve and feedback techniques to control the operational parameters of the ventilator. The proposed dual-mode control mechanism allows dynamic adjustment of the tidal volume, pressure, and duration of ventilation simultaneously. The system has been verified in animal experiments and demonstrated a significant improvement in the gas exchange efficiency. Besides, the bioelectrical impedance measurement can provide real-time and accurate regional information of the lungs, which helps to monitor the patient’s condition during respiratory treatment. This work also adopts wireless communication and remote-control technology to reduce the risk of infection of medical professionals.